MedPath

SOFT TISSUE CHANGES AND BONE LEVELS AROUND DENTAL IMPLANTS WITH LASER

Phase 2
Not yet recruiting
Conditions
Disorder of gingiva and edentulousalveolar ridge, unspecified,
Registration Number
CTRI/2022/06/043270
Lead Sponsor
Dr YNR SUDESHNA TULABANDULA
Brief Summary

The procedure will be performed under local anesthesia using 2% lignocaine containing adrenaline 1:80,000.

Implants will be placed by following surgical procedure in both the groups.

After adequate local anesthesia, a mid-crestal incision is given in both the cases. A mucoperiosteal flap is elevated and bone will be exposed.

Selected size of implants (3.5mm and 10mm) will be placed in group I and group II sites.

The implant site will be prepared with standard drills. The osteotomy site is prepared with sequence of drills to the size of implant.

Sites in group I will be treated with Low Level Laser and group II sites will not be treated with Low Level Laser.

Flaps will be approximated and sutured. Instructions regarding oral hygiene maintenance and soft diet plan will be provided. Patient will be discharged after prescribing analgesics and antibiotic. Patient is recalled after 1 week for suture removal. Crown placement will be done after 3 months.clinical parameters like thickness of keratinized tissue, modified gingival index, modified plaque index, width of the keratinized tissue and crestal bone level (by IOPA radiographs) will be assessed at baseline, 3 months and 6 months.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria
  • 1.Individuals in need of tooth replacement.
  • 2.Presence of adequate keratinized mucosa in the edentulous site.
  • 3.Apparently healthy individuals.
  • 4.Isolated mandibular edentulous sites with adequate bone quality and volume with D2 and D3 type of bone.
  • 5.Individuals with age group of 20-60 years of either gender .
  • 6.Patients who are willing to give informed consent.
Exclusion Criteria
  • 1.Smokers 2.Individuals with parafunctional habits.
  • 3.Pregnant and lactating women.
  • 4.Systemic diseases that contraindicate implant placement and surgical procedure.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
2. To evaluate the peri implant crestal bone levels and soft tissue changes without Low level laser therapy.baseline, 7th day, 6 weeks, 3 months and 6 months after implant placement
1. To evaluate the peri implant crestal bone levels and soft tissue changes with Low level laser therapy.baseline, 7th day, 6 weeks, 3 months and 6 months after implant placement
Secondary Outcome Measures
NameTimeMethod
To compare the soft tissue changes and peri implant crestal bone levels with and without Low level laser therapy.

Trial Locations

Locations (1)

sibar institute of dental sciences-guntur

🇮🇳

Guntur, ANDHRA PRADESH, India

sibar institute of dental sciences-guntur
🇮🇳Guntur, ANDHRA PRADESH, India
Dr YNR SUDESHNA TULABANDULA
Principal investigator
8008013885
tsudeshna13@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.